Oscar Health, Inc. (OSCR): who owns it and who trades it
As of Nov 16, 2026, OSCR insiders reported 59 open-market sales worth $144M and 1 purchase worth $11.9M in the last 12 months, with 79% of the sale value made under pre-set 10b5-1 plans. The largest seller was Mark T Bertolini (CEO), with $70.7M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Oscar Health
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns OSCR
402 funds and institutions reported OSCR shares worth $6B at the end of Q2 2026. The largest holder is BlackRock, Inc. with $587M.
10 largest owners, by value
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 20.59M | – | $587M | +19% |
| T. Rowe Price Investment Management, Inc. | 13.04M | – | $372M | +12% |
| D. E. Shaw & Co., Inc. | 12.64M | – | $361M | +131% |
| Vanguard Portfolio Management LLC | 11.03M | – | $315M | +5% |
| Vanguard Capital Management LLC | 10.58M | – | $302M | -2% |
| American Century Companies Inc | 9.06M | – | $258M | +29% |
| California State Teachers Retirement System | 7.80M | – | $274M | +3214% |
| Jane Street Group, LLC | 6.37M | – | $182M | +119% |
| Thrive Capital Management, LLC | 6.34M | – | $181M | No change |
| Geode Capital Management, LLC | 5.82M | – | $166M | +16% |
| State Street Corp | 5.80M | – | $165M | +10% |
| FMR LLC (Fidelity) | 5.00M | – | $143M | +317% |
| Citadel Advisors LLC | 4.23M | – | $121M | +22% |
| Two Sigma Investments, LP | 4.04M | – | $115M | +72% |
| Dimensional Fund Advisors LP | 3.57M | – | $102M | -15% |
| BIT Capital GmbH | 3.42M | – | $97.5M | -46% |
| Renaissance Technologies LLC | 3.28M | – | $93.7M | – |
| T. Rowe Price Associates | 3.26M | – | $92.9M | +70% |
| Jacobs Levy Equity Management, Inc | 3.03M | – | $86.3M | +22% |
| Glynn Capital Management LLC | 2.58M | – | $73.5M | -1% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, OSCR insiders reported $11.9M of open-market purchases and $144M of sales. 79% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Vanessa Ames Wittman | Director | Sale plan | 25,000 | $32.24 | $806K | Form 4 |
| Sep 3, 2026 | Janet Liang | President | Sale plan | 10,360 | $31.45 | $326K | Form 4 |
| Sep 3, 2026 | Victoria Baltrus | Chief Accounting Officer | Sale plan | 958 | $31.45 | $30.1K | Form 4 |
| Sep 3, 2026 | Richard Scott Blackley | CFO | Sale plan | 28,869 | $31.45 | $908K | Form 4 |
| Sep 3, 2026 | Adam McAnaney | Chief Legal Officer | Sale plan | 9,092 | $31.45 | $286K | Form 4 |
| Sep 3, 2026 | Mario Schlosser | Director | Sale plan | 31,422 | $31.45 | $988K | Form 4 |
| Aug 28, 2026 | Mario Schlosser | Director | Sale | 150,000 | $30.79 | $4.6M | Form 4 |
| Aug 27, 2026 | Mario Schlosser | Director | Sale | 600,000 | $30.34 | $18.2M | Form 4 |
| Aug 18, 2026 | Richard Scott Blackley | CFO | Sale | 18,750 | $31.74 | $595K | Form 4 |
| Jul 1, 2026 | Mario Schlosser | Director | Sale plan | 3,600 | $29.50 | $106K | Form 4 |
| Jul 1, 2026 | Mario Schlosser | Director | Sale plan | 13,672 | $30.80 | $421K | Form 4 |
| Jul 1, 2026 | Mario Schlosser | Director | Sale plan | 30,228 | $31.65 | $957K | Form 4 |
| Jun 30, 2026 | Mark T Bertolini | CEO | Sale plan | 488,654 | $28.35 | $13.9M | Form 4 |
| Jun 30, 2026 | Mark T Bertolini | CEO | Sale plan | 135,590 | $28.97 | $3.9M | Form 4 |
| Jun 29, 2026 | Mark T Bertolini | CEO | Sale plan | 58,926 | $30.08 | $1.8M | Form 4 |
| Jun 29, 2026 | Mark T Bertolini | CEO | Sale plan | 555,826 | $29.17 | $16.2M | Form 4 |
| Jun 26, 2026 | Mark T Bertolini | CEO | Sale plan | 149,795 | $29.79 | $4.5M | Form 4 |
| Jun 26, 2026 | Mark T Bertolini | CEO | Sale plan | 441,373 | $29.11 | $12.8M | Form 4 |
| Jun 25, 2026 | Mark T Bertolini | CEO | Sale plan | 597,942 | $28.60 | $17.1M | Form 4 |
| Jun 25, 2026 | Mark T Bertolini | CEO | Sale plan | 17,200 | $29.08 | $500K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 591,213 | $29.58 | $17.5M | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 1,799 | $30.09 | $54.1K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 16,307 | $28.95 | $472K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 97 | $30.09 | $2.9K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 102 | $30.09 | $3.1K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 16,306 | $28.95 | $472K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 33,592 | $29.58 | $994K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 15,491 | $28.95 | $448K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 31,912 | $29.58 | $944K | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 286,988 | $28.95 | $8.3M | Form 4 |
| Jun 23, 2026 | Mario Schlosser | Director | Sale plan | 33,591 | $29.58 | $994K | Form 4 |
| Jun 2, 2026 | Victoria Baltrus | Chief Accounting Officer | Sale plan | 432 | $22.45 | $9.7K | Form 4 |
| Jun 2, 2026 | Victoria Baltrus | Chief Accounting Officer | Sale plan | 1,091 | $21.74 | $23.7K | Form 4 |
| Jun 2, 2026 | Mario Schlosser | Director | Sale plan | 24,452 | $21.74 | $532K | Form 4 |
| Jun 2, 2026 | Mario Schlosser | Director | Sale plan | 9,668 | $22.45 | $217K | Form 4 |
| Jun 2, 2026 | Adam McAnaney | Chief Legal Officer | Sale plan | 7,065 | $21.74 | $154K | Form 4 |
| Jun 2, 2026 | Adam McAnaney | Chief Legal Officer | Sale plan | 2,794 | $22.45 | $62.7K | Form 4 |
| Jun 2, 2026 | Janet Liang | President | Sale plan | 8,940 | $21.74 | $194K | Form 4 |
| Jun 2, 2026 | Janet Liang | President | Sale plan | 3,535 | $22.45 | $79.4K | Form 4 |
| Jun 2, 2026 | Richard Scott Blackley | CFO | Sale plan | 8,977 | $22.45 | $202K | Form 4 |
| Jun 2, 2026 | Richard Scott Blackley | CFO | Sale plan | 22,706 | $21.74 | $494K | Form 4 |
| May 18, 2026 | Richard Scott Blackley | CFO | Sale plan | 110,000 | $25.03 | $2.8M | Form 4 |
| May 14, 2026 | Richard Scott Blackley | CFO | Sale plan | 91,259 | $23.10 | $2.1M | Form 4 |
| May 14, 2026 | Richard Scott Blackley | CFO | Sale plan | 8,741 | $23.79 | $208K | Form 4 |
| Apr 6, 2026 | Mark T Bertolini | CEO | Purchase | 1.00M | $11.92 | $11.9M | Form 4 |
| Mar 2, 2026 | Janet Liang | President | Sale plan | 7,453 | $13.39 | $99.8K | Form 4 |
| Mar 2, 2026 | Victoria Baltrus | Chief Accounting Officer | Sale plan | 4,638 | $13.39 | $62.1K | Form 4 |
| Mar 2, 2026 | Adam McAnaney | Chief Legal Officer | Sale plan | 18,710 | $13.39 | $251K | Form 4 |
| Mar 2, 2026 | Mario Schlosser | President | Sale plan | 24,335 | $13.39 | $326K | Form 4 |
| Mar 2, 2026 | Richard Scott Blackley | CFO | Sale plan | 19,221 | $13.39 | $257K | Form 4 |
| Jan 8, 2026 | Mario Schlosser | President | Sale | 23,038 | $17.65 | $407K | Form 4 |
| Jan 6, 2026 | Mario Schlosser | President | Sale | 76,962 | $17.01 | $1.3M | Form 4 |
| Jan 5, 2026 | Mario Schlosser | President | Sale | 96,928 | $15.64 | $1.5M | Form 4 |
| Jan 2, 2026 | Mario Schlosser | President | Sale | 137,933 | $15.02 | $2.1M | Form 4 |
| Dec 24, 2025 | Mario Schlosser | President | Sale | 38,835 | $15.00 | $583K | Form 4 |
| Dec 2, 2025 | Adam McAnaney | Chief Legal Officer | Sale | 1,852 | $16.59 | $30.7K | Form 4 |
| Dec 2, 2025 | Mario Schlosser | President | Sale | 23,965 | $16.59 | $398K | Form 4 |
| Dec 2, 2025 | Janet Liang | President | Sale | 7,338 | $16.59 | $122K | Form 4 |
| Dec 2, 2025 | Richard Scott Blackley | CFO | Sale | 25,135 | $16.59 | $417K | Form 4 |
| Dec 2, 2025 | Victoria Baltrus | Chief Accounting Officer | Sale | 4,149 | $16.59 | $68.8K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Mark T Bertolini | Chief Executive Officer, Director | $11.9M | $70.7M | Jun 30, 2026 |
| Mario Schlosser | President of Technology & CTO, Director | – | $62.8M | Sep 3, 2026 |
| Richard Scott Blackley | Chief Financial Officer | – | $7.9M | Sep 3, 2026 |
| Janet Liang | President, Oscar Insurance | – | $821K | Sep 3, 2026 |
| Vanessa Ames Wittman | Director | – | $806K | Sep 18, 2026 |
| Adam McAnaney | Chief Legal Officer | – | $784K | Sep 3, 2026 |
| Victoria Baltrus | Chief Accounting Officer | – | $194K | Sep 3, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
OSCR short interest
16.73M OSCR shares are sold short. Over the last 12 reports the number of shares short went down 9%.
As of Oct 30, 2026, 16.73M OSCR shares were sold short, down 8.5% from the report before. At the average daily volume of 4.27M shares, buying them all back would take about 3.9 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 16.73M | – | -9% | 4.27M | 3.9 |
| Oct 15, 2026 | 18.29M | – | +11% | 4.90M | 3.7 |
| Sep 30, 2026 | 16.45M | – | -7% | 6.14M | 2.7 |
| Sep 15, 2026 | 17.77M | – | +9% | 4.87M | 3.6 |
| Aug 31, 2026 | 16.36M | – | -0% | 4.71M | 3.5 |
| Aug 14, 2026 | 16.44M | – | -8% | 7.04M | 2.3 |
| Jul 31, 2026 | 17.83M | – | -9% | 4.36M | 4.1 |
| Jul 15, 2026 | 19.58M | – | +4% | 4.89M | 4.0 |
| Jun 30, 2026 | 18.74M | – | +7% | 6.84M | 2.7 |
| Jun 15, 2026 | 17.47M | – | -3% | 8.61M | 2.0 |
| May 29, 2026 | 17.99M | – | -2% | 7.01M | 2.6 |
| May 15, 2026 | 18.39M | – | -25% | 10.13M | 1.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Oscar Health company events
Oscar Health filed 11 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Sep 16, 2026AnnouncementShared information with investors. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jun 9, 2026VoteReported shareholder vote results. Filing
- Jun 8, 2026AnnouncementShared information with investors. Filing
- Jun 2, 2026LeadershipOscar Health, Inc. and Oscar Management Corporation (together, the “Company”) and Mario Schlosser entered into an amended and restated employment agreement, effective as of June 1, 2026, in connection with Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the… Filing
- May 6, 2026ResultsReleased financial results. Filing
- Apr 21, 2026AnnouncementShared information with investors. Filing
- Mar 2, 2026AnnouncementShared information with investors. Filing
- Feb 10, 2026AgreementOscar Health, Inc., entered into a $475.0 million secured three-year revolving credit facility, pursuant to a Credit Agreement, by and among the Company, certain subsidiaries of the Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto. Filing
- Dec 29, 2025LeadershipOscar Health, Inc. and Oscar Management Corporation (together, the “Company”) entered into an amended and restated employment agreement with Mark T. Bertolini in connection with the forthcoming expiration of the initial employment term under the employment agreement that Mr. Bertolini previously… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Oscar Health financials
Famous investors that hold OSCR
5 of the 50 well-known investors we track reported holding OSCR in their latest 13F filing. The largest position is Ken Griffin's, worth $174M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 5.63M | $174M | 0.1% | +33% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 3.85M | $119M | 0.2% | +17% |
| Israel Englander · Millennium Management | Q3 2026 | 1.45M | $44.9M | 0.0% | +127% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 1.12M | $34.5M | 0.2% | +423% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 935,630 | $28.9M | 0.0% | +17% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Oscar Health, Inc. (OSCR) stock
Who owns the most OSCR stock?
The largest reported owner of Oscar Health, Inc. (OSCR) is BlackRock, Inc.. In total, 402 funds and institutions reported holding OSCR at the end of Q2 2026. See the largest owners.
Are OSCR insiders buying or selling?
In the last 12 months, OSCR insiders reported 1 open-market purchase worth $11.9M and 59 sales worth $144M. The latest trade was on Sep 18, 2026. See every trade.
What is the short interest in OSCR?
As of Oct 30, 2026, 16.73M OSCR shares were sold short, down 8.5% from the report before. At the average daily volume of 4.27M shares, buying them all back would take about 3.9 trading days (days to cover). See the history.
Which famous investors hold OSCR?
5 of the 50 well-known investors we track reported OSCR in their latest 13F filing, including Ken Griffin, Jim Simons, Israel Englander. The largest position is worth $174M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.